Crinetics' Once-Daily Oral Paltusotine Achieved the Primary
83% of Participants on Paltusotine Maintained IGF-1 ≤1.0 xULN vs. 4% on placebo (p<0.0001) Mean IGF-1 Levels Were Maintained on Paltusotine vs. an...
Source: globenewswire.com
After Switching News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from After Switching. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.